IFNG and macrophage activation syndrome: Interestingly, in this study, both IFN-γ wild-type and knockout mice developed an MAS/HLH-like syndrome following exposure to a TLR9 agonist, suggesting that the clinical phenotype was not mediated by IFN-γ alone.